ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 48 filers reported holding ACORDA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $29,000 | +2800.0% | 42,410 | +2752.1% | 0.00% | – |
| Q3 2020 | $1,000 | -97.0% | 1,487 | -86.9% | 0.00% | -100.0% |
| Q3 2019 | $33,000 | +65.0% | 11,367 | +638.1% | 0.00% | +100.0% |
| Q1 2019 | $20,000 | +300.0% | 1,540 | +342.5% | 0.00% | – |
| Q4 2018 | $5,000 | -68.8% | 348 | -56.5% | 0.00% | -100.0% |
| Q3 2018 | $16,000 | -23.8% | 800 | -9.0% | 0.00% | -50.0% |
| Q1 2018 | $21,000 | -30.0% | 879 | -37.9% | 0.00% | -50.0% |
| Q4 2017 | $30,000 | +20.0% | 1,416 | +33.8% | 0.00% | +100.0% |
| Q3 2017 | $25,000 | -26.5% | 1,058 | -33.9% | 0.00% | -33.3% |
| Q1 2017 | $34,000 | -71.4% | 1,600 | -74.6% | 0.00% | -76.9% |
| Q4 2016 | $119,000 | +52.6% | 6,289 | +106.7% | 0.01% | +85.7% |
| Q2 2016 | $78,000 | +3800.0% | 3,043 | +4068.5% | 0.01% | – |
| Q1 2016 | $2,000 | -77.8% | 73 | -63.5% | 0.00% | -100.0% |
| Q4 2015 | $9,000 | +800.0% | 200 | +952.6% | 0.00% | – |
| Q3 2015 | $1,000 | -99.0% | 19 | -99.3% | 0.00% | -100.0% |
| Q2 2015 | $96,000 | -29.4% | 2,884 | -29.3% | 0.01% | -47.1% |
| Q1 2015 | $136,000 | +223.8% | 4,079 | +294.1% | 0.02% | +325.0% |
| Q4 2014 | $42,000 | -73.4% | 1,035 | -77.7% | 0.00% | -77.8% |
| Q3 2014 | $158,000 | – | 4,651 | +465000.0% | 0.02% | – |
| Q1 2014 | $0 | -100.0% | 1 | -97.4% | 0.00% | – |
| Q4 2013 | $1,000 | -98.9% | 38 | -98.6% | 0.00% | -100.0% |
| Q3 2013 | $93,000 | +257.7% | 2,727 | +245.6% | 0.01% | +400.0% |
| Q2 2013 | $26,000 | – | 789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|